Betterlife Pharma Inc
(BETRF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 01/31
| 07-2024 | 04-2024 | 01-2024 | 10-2023 | 07-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,554 | -1,509 | -2,147 | -1,623 | -1,492 |
| Accounts receivable | 11 | 13 | -17 | 3 | 4 |
| Other Working Capital | -258 | -357 | 238 | -119 | -269 |
| Other Operating Activity | 1,443 | 1,221 | 94 | 106 | 392 |
| Operating Cash Flow | $-1,359 | $-633 | $-1,831 | $-1,632 | $-1,365 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 902 | 222 | N/A | N/A |
| Common Stock Issued | N/A | 15 | 1,631 | 1,694 | 1,404 |
| Other Financing Activity | 1,424 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $1,424 | $916 | $1,853 | $1,694 | $1,404 |
| Beginning Cash Position | 27 | 28 | 6 | 6 | 6 |
| End Cash Position | 92 | 311 | 28 | 68 | 46 |
| Net Cash Flow | $65 | $284 | $22 | $62 | $40 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,359 | -633 | -1,831 | -1,632 | -1,365 |
| Free Cash Flow | -1,359 | -633 | -1,831 | -1,632 | -1,365 |